Posterior Reversible Encephalopathy Syndrome Associated With Dose-adjusted EPOCH (Etoposide,Prednisone, Vincristine,Cyclophosphamide, Doxorubicin) Chemotherapy |
| |
| Affiliation: | 1. Seattle Cancer Care Alliance, Seattle, WA;2. Department of Neurology, University of Washington School of Medicine, Seattle, WA;3. Department of Medicine, University of Washington School of Medicine, Seattle, WA;4. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;1. Department of Emergency Medicine, University of Washington Medical Center, Seattle, Washington;2. Division of Cardiology, University of Washington Medical Center, Seattle, Washington;1. Associação Beneficente de Coleta de Sangue (Colsan), São Paulo, SP, Brazil;2. Universidade Federal de São Paulo (Unifesp), Departamento de Medicina, São Paulo, SP, Brazil;1. Department of Pharmacy, University of Peshawar, Peshawar, Pakistan;2. Department of Pharmacy, COMSATS Institute of Information Technology, Abbottabad, Pakistan;3. Department of Pharmacy, Sarhad University of Science and Information Technology, Peshawar, Pakistan;1. Rotman Research Institute, Baycrest Centre, Toronto, Canada;2. Department of Psychology, Trent University, Peterborough, Canada;3. Departments of Psychology and Psychiatry, University of Toronto, Toronto, Canada;4. School of Psychology, The University of Sydney, Sydney, Australia;5. Normandie Univ, UNIROUEN, INSERM, DC2N, 76000 Rouen, France;6. Institute for Research and Innovation in Biomedicine (IRIB), 76000 Rouen, France;7. Cancer and Cognition Platform, Ligue Nationale contre le Cancer, Caen, France;1. School of Food Science and Engineering, Hefei University of Technology, Hefei, Anhui 230009, PR China;2. School of Biological and Medical Engineering, Hefei University of Technology, Hefei, Anhui 230009, PR China |
| |
| Abstract: | ![]()
|
| |
| Keywords: | Antineoplastic Infection Intrathecal Neurotoxicity Risk factor |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
